Mylan to acquire Abbott's non-US branded generics pharma business

07:18 AM | July 18, 2014 | Natasha Alperowicz

Mylan (Pittsburgh) has entered into a definitive agreement with Abbott to acquire Abbott's non-US developed markets specialty and branded generics business in an all-stock transaction. Abbott will...